XML 24 R12.htm IDEA: XBRL DOCUMENT v3.25.3
Revenues and Deferred Costs
 9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenues and Deferred Costs Revenues and Deferred Costs
The following table disaggregates the Company's revenue by major source for the three and nine months ended September 30, 2025 and 2024:

Three months ended September 30,
Nine months ended September 30,
(in thousands)2025202420252024
SaaS subscription services$107,867 $82,054 $306,534 $233,437 
Implementation services3,509 1,832 9,025 5,790 
Other services1,578 2,020 7,289 4,966 
Total revenues$112,954 $85,906 $322,848 $244,193 

The Company recognized approximately $9.3 million of revenue during the nine months ended September 30, 2025 that was included in deferred revenues in the accompanying condensed consolidated balance sheets as of the beginning of the reporting period. For those contracts that were wholly or partially unsatisfied as of September 30, 2025, the Company’s remaining performance obligation totaled approximately $1.6 billion. The Company expects to recognize approximately 49.9% of these remaining obligations as revenue over the next 24 months, an additional 34.2% in the next 25 to 48 months, and the remaining balance thereafter. This estimate does not include estimated consideration for excess user and transaction processing fees that the Company expects to earn under its subscription contracts.

Contract assets totaled $2.9 million, including $0.2 million related to MANTL, and $1.9 million as of September 30, 2025 and December 31, 2024, respectively, which are included in other assets in the accompanying condensed consolidated balance sheets.

Deferred Cost Recognition

The Company capitalized $3.9 million and $7.4 million in deferred commissions costs during the three and nine months ended September 30, 2025, respectively, and $3.1 million and $6.0 million for the three and nine months ended September 30, 2024, respectively, and recognized amortization of $1.5 million and $4.6 million during the three and nine months ended September 30, 2025, respectively, and $1.3 million and $3.8 million during the three and nine months ended September 30, 2024, respectively. Amortization expense is included in sales and marketing expenses in the accompanying condensed consolidated statements of operations. Deferred commissions are considered costs to obtain a contract and are included in deferred costs in the accompanying condensed consolidated balance sheets in the amount of $28.7 million and $25.9 million as of September 30, 2025 and December 31, 2024, respectively.

The Company capitalized implementation costs of $3.5 million and $8.8 million during the three and nine months ended September 30, 2025, respectively, and $2.4 million and $7.6 million for the three and nine months ended September 30, 2024, respectively, and recognized amortization of $1.5 million and $4.5 million for the three and nine months ended September 30, 2025, respectively, and $1.4 million and $4.1 million during the three and nine months ended September 30, 2024, respectively. Amortization expense is included in cost of revenues in the accompanying condensed consolidated statements of operations. These deferred costs are considered costs to fulfill client contracts and are included in deferred costs in the accompanying condensed consolidated balance sheets in the amount of $28.8 million and $24.5 million as of September 30, 2025 and December 31, 2024, respectively.

The Company periodically reviews the carrying amount of deferred costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. No material impairment losses were recognized in relation to these capitalized costs for the three or nine months ended September 30, 2025 and 2024.